全文获取类型
收费全文 | 1452篇 |
免费 | 144篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 53篇 |
妇产科学 | 20篇 |
基础医学 | 146篇 |
口腔科学 | 4篇 |
临床医学 | 188篇 |
内科学 | 322篇 |
皮肤病学 | 8篇 |
神经病学 | 59篇 |
特种医学 | 114篇 |
外科学 | 230篇 |
综合类 | 60篇 |
一般理论 | 1篇 |
预防医学 | 140篇 |
眼科学 | 5篇 |
药学 | 74篇 |
中国医学 | 1篇 |
肿瘤学 | 191篇 |
出版年
2022年 | 9篇 |
2021年 | 13篇 |
2020年 | 9篇 |
2019年 | 18篇 |
2018年 | 19篇 |
2017年 | 13篇 |
2016年 | 16篇 |
2015年 | 25篇 |
2014年 | 24篇 |
2013年 | 43篇 |
2012年 | 49篇 |
2011年 | 64篇 |
2010年 | 42篇 |
2009年 | 37篇 |
2008年 | 55篇 |
2007年 | 63篇 |
2006年 | 81篇 |
2005年 | 62篇 |
2004年 | 54篇 |
2003年 | 50篇 |
2002年 | 48篇 |
2001年 | 49篇 |
2000年 | 52篇 |
1999年 | 59篇 |
1998年 | 40篇 |
1997年 | 27篇 |
1996年 | 29篇 |
1995年 | 31篇 |
1994年 | 26篇 |
1993年 | 29篇 |
1992年 | 33篇 |
1991年 | 37篇 |
1990年 | 41篇 |
1989年 | 46篇 |
1988年 | 32篇 |
1987年 | 36篇 |
1986年 | 22篇 |
1985年 | 22篇 |
1984年 | 22篇 |
1983年 | 15篇 |
1982年 | 25篇 |
1981年 | 14篇 |
1980年 | 13篇 |
1979年 | 23篇 |
1978年 | 8篇 |
1976年 | 6篇 |
1974年 | 9篇 |
1973年 | 16篇 |
1972年 | 7篇 |
1970年 | 6篇 |
排序方式: 共有1623条查询结果,搜索用时 18 毫秒
101.
M C Hanssens C Selby G M Filshie B J Gilbert E M Symonds 《British journal of obstetrics and gynaecology》1983,90(9):847-853
Peripheral plasma concentrations of unconjugated oestradiol 17-beta, progesterone and total oestriol were measured in 21 patients presenting with 'uncomplicated' preterm labour. Serial measurements were made during intravenous treatment with ritodrine over a period of 24 h. Mean levels of unconjugated oestradiol 17-beta fell significantly during infusion with ritodrine. Changes in progesterone levels remained within the range of diurnal fluctuations normally found in uncomplicated late pregnancy. Mean total oestriol levels fell significantly, but the changes did not exceed normal variations. No correlation was found between the magnitude, the rate or the timing of changes in any of the hormones measured and the short or long term effects of ritodrine on uterine activity. Although alterations in the peripheral oestrogen concentrations may be a direct effect of beta-mimetics, it is unlikely that this mechanism is important in the inhibition of uterine activity. 相似文献
102.
103.
104.
105.
106.
Uflacker R Rajagopalan PR Selby JB Hannegan C;Investigators of the Clinical Trial Sponsored by Microvena Corporation 《European radiology》2004,14(11):2009-2014
We report the final results of the trial comparing the Amplatz thrombectomy device (ATD) with surgical thromboembolectomy (ST) to declot thrombosed dialysis access grafts (DAG). The study population consisted of 174 DAG, 109 of which were randomized to mechanical thrombectomy using the ATD and 65 of which were randomized to conventional surgical thromboembolectomy. Forty grafts were re-enrolled in the trial when they failed beyond the 90 days follow-up after the initial treatment. Thirty-one were re-enrolled for mechanical thrombectomy and nine were re-enrolled for surgical thrombectomy, resulting in a total of 140 ATD procedures and 74 surgical thromboembolectomy. Immediate thrombectomy success was defined as greater than 90% thrombus removal followed by the ability to dialyze after treatment, and analysis of long term success based on graft patency at 30 and 90 days, with successful dialysis. Immediate thrombectomy success with the ATD procedure was achieved in 79.2% and with ST in 73.4%. Patency of the graft, with successful dialysis, at 30 days with the ATD procedure was 79.2% and with ST was 73.4%. Patency of the graft, with successful dialysis, at 90 days with the ATD procedure was 75.2% and with ST was 67.8%. The data collected in this study provided a prospective comparison of mechanical thrombectomy with the ATD and ST performance in thrombosed DAG. The results of the performance of both methods were comparable. No statistically significant differences were seen.List of Investigators: Carol C. Steenson (Department of Radiology, VA Medical Center, Minneapolis, MN), Renan Uflacker (Interventional Radiology, Medical University of South Carolina, Charleston, SC), Richard J. Gray (Interventional Radiology, Washington Hospital Center, Washington, DC), George A. Fueredi (St Marys Hospital, Milwaukee, WI), Michael P. Hickman (Vascular and Interventional Radiology, St Josephs Regional Health Center, Hot Springs, AR), Robert Smith (Interventional Radiology, Tulane University Medical Center, New Orleans, LA), Paul Kamin (Department of Radiology, Los Alamitos Medical Center, Los Alamitos, CA), Mac Dryjski (Department of Surgery, Millard Filmore Hospital, Buffalo, NY), Michael Bettman (Vascular and Interventional Radiology, Dartmouth-Hitchcock Medical Center, Lebanon, NH). 相似文献
107.
Hall GD Brown JM Coleman RE Stead M Metcalf KS Peel KR Poole C Crawford M Hancock B Selby PJ Perren TJ 《British journal of cancer》2004,91(4):621-626
A randomised phase III trial was conducted to assess the role of interferon-alpha (INFalpha) 2a as maintenance therapy following surgery and/or chemotherapy in patients with epithelial ovarian carcinoma. Patients were randomised following initial surgery/chemotherapy to interferon-alpha 2a as 4.5 mega-units subcutaneously 3 days per week or to no further treatment. A total of 300 patients were randomised within the study between February 1990 and July 1997. No benefit for interferon maintenance was seen in terms of either overall or clinical event-free survival. We conclude that INF-alpha is not effective as a maintenance therapy in the management of women with ovarian cancer. The need for novel therapeutics or strategies to prevent the almost inevitable relapse of patients despite increasingly effective surgery and chemotherapy remains. 相似文献
108.
Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes 下载免费PDF全文
Rosen AB Karter AJ Liu JY Selby JV Schneider EC 《Journal of general internal medicine》2004,19(6):669-675
BACKGROUND: Diabetes causes 45% of incident end-stage renal disease (ESRD). Risk of progression is higher in those with clinical risk factors (albuminuria and hypertension), and in ethnic minorities (including blacks, Asians, and Latinos). Angiotensin-converting enzyme inhibitors (ACE) and angiotensin receptor blockers (ARB) slow the progression of diabetic nephropathy, yet little is known about their use among patients at high risk for progression to ESRD. OBJECTIVES: To examine the prevalence of ACE or ARB (ACE/ARB) use overall and within patients with high-risk clinical indications, and to assess for ethnic disparities in ACE/ARB use. DESIGN: Observational cohort study. SETTING: Kaiser Permanente Northern California (KPNC) Diabetes Registry, a longitudinal registry that monitors quality and outcomes of care for all KPNC patients with diabetes. PATIENTS: Individuals (N= 38887) with diabetes who were continuously enrolled with pharmacy benefits during the year 2000, and had self-reported ethnicity data on survey. INTERVENTIONS AND MEASUREMENTS: Pharmacy dispensing of ACE/ARB. RESULTS: Forty-one percent of the cohort had both hypertension and albuminuria, 30% had hypertension alone, and 12% had albuminuria alone. Fourteen percent were black, 11% Latino, 13% Asian, and 63% non-Latino white. Overall, 61% of the cohort received an ACE/ARB. ACE/ARB was dispensed to 74% of patients with both hypertension and albuminuria, 64% of those with hypertension alone, and 54% of those with albuminuria alone. ACE/ARB was dispensed to 61% of whites, 63% of blacks, 59% of Latinos, and 60% of Asians. Among those with albuminuria alone, blacks were significantly (P =.0002) less likely than whites to receive ACE/ARB (47% vs 56%, respectively). No other ethnic disparities were found. CONCLUSIONS: In this cohort, the majority of eligible patients received indicated ACE/ARB therapy in 2000. However, up to 45% to 55% of high-risk clinical groups (most notably individuals with isolated albuminuria) were not receiving indicated therapy. Additional targeted efforts to increase use of ACE/ARB could improve quality of care and reduce ESRD incidence, both overall and in high-risk ethnic groups. Policymakers might consider use of ACE/ARB for inclusion in diabetes performance measurement sets. 相似文献
109.
Spacey SD Szczygielski BI Young SP Hukin J Selby K Snutch TP 《The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques》2004,31(3):383-386
BACKGROUND: Friedrich ataxia (FRDA1) is most often the result of a homozygous GAA repeat expansion in the first intron of the frataxin gene (FRDA gene). This condition is seen in individuals of European, North African, Middle Eastern and Indian descent and has not been reported in Southeast Asian populations. Approximately 4% of FRDA1 patients are compound heterozygotes. These patients have a GAA expansion on one allele and a point mutation on the other and have been reported to have an atypical phenotype. OBJECTIVE: To describe a novel dinucleotide deletion in the FRDA gene in two Malaysian siblings with FRDA1. SETTING: Tertiary referral university hospital setting. PATIENTS AND METHODS: A previously healthy 10-year-old Malaysian boy, presented with fever, lethargy, headaches, dysarthria, dysphagia, vertigo and ataxia which developed over a one week period. His neurological exam revealed evidence of dysarthria and ataxia, mild generalized weakness and choreoform movements of the tongue and hands. His reflexes were absent and Babinski sign was present bilaterally. A nine-year-old sister was found to have mild ataxia but was otherwise neurologically intact. RESULTS: Molecular genetic studies demonstrated that both siblings were compound heterozygotes with a GAA expansion on one allele and a novel dinucleotide deletion on the other allele. CONCLUSIONS: We describe a novel dinucleotide deletion in the first exon of the FRDA gene in two siblings with FRDA1. Additionally this is the first report of FRDA1 occurring in a family of southeast Asian descent, it demonstrates intrafamilial phenotypic variability, and confirms that atypical phenotypes are associated with compound heterozygosity. 相似文献
110.